Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant chemoradiation with cisplatin plus fluorouracil for esophageal cancer
jRCT1041180004Phase 2Completed
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in esophageal cancer. Primary endpoint: Response rate. Started Sep 2018; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCT1041180004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041180004.